Ana I. Casanegra - Concepedia

Author

Ana I. Casanegra

Also Known As

A CASANEGRA, A Casanegra, A I Casanegra, A. Casanegra, A.I. Casanegra, Ana Casanegra, Ana I Casanegra, Ana I. Casanegra, Ana Isabel Casanegra

144

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic in Florida Mayo Clinic Mayo Clinic in Arizona University of Oklahoma Health Sciences Center WinnMed

About

Ana I. Casanegra is an author at Mayo Clinic in Florida specializing in medicine, thrombosis, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	577
2	Health Sciences	6	6	230
3	Public Health	4	4	130
4	Emergency Medicine	4	4	89
5	Applied Physiology	2	2	75

Ana I. Casanegra

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer‐associated venous thromboembolism Waldemar E. Wysokiński, Damon E. Houghton, Ana I. Casanegra, American Journal of Hematology Recurrent VtePharmacotherapyLogistic AnalysisAcute Ca-vteThrombosis	2019	72
Bivalirudin for the treatment of patients with confirmed or suspected heparin‐induced thrombocytopenia Lee Joseph, Ana I. Casanegra, Manoj Dhariwal, Journal of Thrombosis and Haemostasis ThrombosisHeparin‐induced ThrombocytopeniaBlood PlateletHematologyCoagulopathy	2014	71
Gender and racial differences in endothelial oxidative stress and inflammation in patients with symptomatic peripheral artery disease Andrew W. Gardner, Donald E. Parker, Polly S. Montgomery, Journal of Vascular Surgery InflammationMetabolic SyndromeVascular DiseaseEndothelial Oxidative StressCardiovascular Epidemiology	2014	70
Ovarian Vein Thrombosis Charles J. Lenz, Waldemar E. Wysokiński, Stanislav Henkin, Obstetrics and Gynecology	2017	56
Association between gait characteristics and endothelial oxidative stress and inflammation in patients with symptomatic peripheral artery disease Andrew W. Gardner, Polly S. Montgomery, Ana I. Casanegra, AGE InflammationMetabolic SyndromeVascular DiseaseEndothelial Oxidative StressHealth Sciences	2016	47
Impaired Vascular Endothelial Growth Factor A and Inflammation in Patients With Peripheral Artery Disease Andrew W. Gardner, Donald E. Parker, Polly S. Montgomery, Angiology	2013	46
Risk of venous thromboembolism after COVID‐19 vaccination Damon E. Houghton, Waldemar E. Wysokiński, Ana I. Casanegra, Journal of Thrombosis and Haemostasis VaccinationThrombosisVaccine SafetyCovid‐19 VaccinationVenous Thrombosis	2022	44
Venous and arterial thrombosis in patients with VEXAS syndrome Yael Kusne, Atefeh Ghorbanzadeh, Alina Dulau-Florea, Blood	2024	43
Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism Dalene Bott‐Kitslaar, Robert D. McBane, Ana I. Casanegra, Mayo Clinic Proceedings ThrombosisVenous DiseaseVenous ThrombosisCardiovascular DiseaseAcute Venous Thromboembolism	2019	41
Bleeding in Patients With Gastrointestinal Cancer Compared With Nongastrointestinal Cancer Treated With Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism Damon E. Houghton, Danielle T. Vlazny, Ana I. Casanegra, Mayo Clinic Proceedings ThrombosisVenous ThrombosisMedicineAcute Venous ThromboembolismHematology	2021	38

Page 1